Companies › CVKD

CADRENAL THERAPEUTICS INC (CVKD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001937993 · EDGAR filings · Updated 2026-07-23

CADRENAL THERAPEUTICS INC (CVKD) has reported institutional ownership of 3.6%, with 17 institutional managers holding positions valued at $459.4K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-23 — PRE 14A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Current report (8-K) filed
• 2026-07-20 — EFFECT filed
• 2026-07-20 — Prospectus supplement (424B3) filed
• 2026-07-17 — Current report (8-K) filed
• 2026-07-15 — D filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CADRENAL THERAPEUTICS INC has 17 institutional holders and institutional ownership of 3.6%.

Insider activity

Insiders reported 23 transactions (0 buys, 23 sells) across 3 reporting insiders, with a net reported value of −$709.8K.

Data flags from SEC filings

Related companies

CALIDI BIOTHERAPEUTICS INC (CLDI) · EXOZYMES INC (EXOZ) · GeoVax Labs Inc (GOVX) · XENETIC BIOSCIENCES INC (XBIO) · PROCESSA PHARMACEUTICALS INC (PCSA) · Pulmatrix Inc (PULM)